Adam H. Schechter is the CEO of Labcorp Holdings, taking the helm on November 1, 2019. Before leading Labcorp, he gained valuable experience as the Executive Vice President and President of Global Human Health at Merck & Co. Adam is...
Adam H. Schechter is the CEO of Labcorp Holdings, taking the helm on November 1, 2019. Before leading Labcorp, he gained valuable experience as the Executive Vice President and President of Global Human Health at Merck & Co. Adam is not just an executive but also has been active on various boards, including the European Federation of Pharmaceutical Industries and Associations. He is involved with organizations like Water.org and the National Alliance for Hispanic Health. Under Adam's leadership, Labcorp has been seen making significant strides, especially during critical times as the healthcare landscape evolved. He received a sign-on grant that bolstered his stock holdings, aligning his interests with those of the company. In 2023, Adam's total compensation was about $2.2 million, which includes a base salary of $1.2 million and performance-based bonuses. Interestingly, his stock holdings have significantly increased over the years. In June 2023, his reported holdings were at an impressive $17.01 million, reflecting his stake in the company's future.